Clinical Trial Update: GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Clinical trial update of a Phase 2 study evaluating GM-CSF, Rituximab, and combination chemotherapy in patients with previously untreated advanced follicular ly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Leukine (sargramostim)
• Rituximab (rituximab)

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: Lymphoma | Phase 2 | Status: UNKNOWN